{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:16:35Z","timestamp":1784106995824,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00430-019-00648-z","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T16:02:46Z","timestamp":1574956966000},"page":"109-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Alternative pathway of complement activation has a beneficial role against Chandipura virus infection"],"prefix":"10.1007","volume":"209","author":[{"given":"Pooja","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-3819","authenticated-orcid":false,"given":"Anuradha S.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"648_CR1","first-page":"1295","volume":"55","author":"PN Bhatt","year":"1967","unstructured":"Bhatt PN, Rodrigues FM (1967) Chandipura: a new arbovirus isolated in India from patients with febrile illness. Indian J Med Res 55:1295\u20131305","journal-title":"Indian J Med Res"},{"key":"648_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(04)16982-1","volume":"364","author":"BL Rao","year":"2004","unstructured":"Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA, Thakare JP, Jadi RS, Rao KA, Mishra AC (2004) A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus. Lancet 364:869\u2013874","journal-title":"Lancet"},{"key":"648_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jmv.21041","volume":"80","author":"BV Tandale","year":"2004","unstructured":"Tandale BV, Tikute SS, Arankalle VA, Sathe PS, Joshi MV, Ranadive SN, Kanojia PC, Eshwarachary D, Kumarswamy M, Mishra AC (2004) Chandipura virus: a major cause of acute encephalitis in children in north Telangana, Andhra Pradesh, India. J Med Virol 80:118\u2013124","journal-title":"J Med Virol"},{"key":"648_CR4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4269\/ajtmh.2005.73.566","volume":"73","author":"MS Chadha","year":"2005","unstructured":"Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, Mahadev PV, Mishra AC (2005) An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat State, India. Am J Trop Med Hyg 73:566\u2013570","journal-title":"Am J Trop Med Hyg"},{"key":"648_CR5","first-page":"395","volume":"132","author":"YK Gurav","year":"2010","unstructured":"Gurav YK, Tandale BV, Jadi RS, Gunjikar RS, Tikute SS, Jamgaonkar AV (2010) Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. Indian J Med Res 132:395\u2013399","journal-title":"Indian J Med Res"},{"key":"648_CR6","first-page":"185","volume":"28","author":"B Dwibedi","year":"2015","unstructured":"Dwibedi B, Sabat J, Hazra RK, Kumar A, Dinesh DS, Kar SK (2015) Chandipura virus infection causing encephalitis in a tribal population of Odisha in eastern India. Natl Med J India 28:185\u2013187","journal-title":"Natl Med J India"},{"key":"648_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10540-007-9054-z","volume":"27","author":"S Basak","year":"2007","unstructured":"Basak S, Mondal A, Polley S, Mukhopadhyay S, Chattopadhyay D (2007) Reviewing Chandipura: a vesiculovirus in human epidemics. Biosci Rep 27:275\u2013298","journal-title":"Biosci Rep"},{"key":"648_CR8","first-page":"25","volume":"54","author":"NS Rao","year":"2008","unstructured":"Rao NS, Wairagkar NS, Mohan MV, Khetan M, Somavathi S (2008) Brain stem encephalitis associated with Chandipura virus in Andhra Pradesh outbreak. J Trop Pediatr 54:25\u201330","journal-title":"J Trop Pediatr"},{"key":"648_CR9","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.vaccine.2009.02.089","volume":"27","author":"CH Venkateswarlu","year":"2009","unstructured":"Venkateswarlu CH, Arankalle VA (2009) Recombinant glycoprotein based vaccine for Chandipura virus infection. Vaccine 27:2845\u20132850","journal-title":"Vaccine"},{"key":"648_CR10","first-page":"21","volume":"30","author":"S Ghosh","year":"2017","unstructured":"Ghosh S, Basu A (2017) Neuropathogenesis by Chandipura virus: an acute encephalitis syndrome in India. Natl Med J India 30:21\u201325","journal-title":"Natl Med J India"},{"key":"648_CR11","first-page":"1","volume":"5","author":"S Kumar","year":"2010","unstructured":"Kumar S, Arankalle VA (2010) Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis. PLoS One 5:1\u201313","journal-title":"PLoS One"},{"key":"648_CR12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.antiviral.2013.09.003","volume":"100","author":"A Roy","year":"2013","unstructured":"Roy A, Chakraborty P, Polley S, Chattopadhyay D, Roy S (2013) A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus\u2014an emerging Rhabdovirus. Antivir Res 100:346\u2013355","journal-title":"Antivir Res"},{"key":"648_CR13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.vaccine.2009.11.072","volume":"28","author":"CH Venkateswarlu","year":"2010","unstructured":"Venkateswarlu CH, Arankalle VA (2010) Evaluation of the immunogenicity of a recombinant glycoprotein-based Chandipura vaccine in combination with commercially available DPT vaccine. Vaccine 28:1463\u20131467","journal-title":"Vaccine"},{"key":"648_CR14","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1016\/j.vaccine.2011.04.063","volume":"29","author":"RS Jadi","year":"2011","unstructured":"Jadi RS, Anakkathil SB, Barde PV, Arankalle VA, Mishra AC (2011) Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: vesiculovirus). Vaccine 29:4613\u20134617","journal-title":"Vaccine"},{"key":"648_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1994","volume":"7","author":"C Kemper","year":"2007","unstructured":"Kemper C, Atkinson JP (2007) T-cell regulation: with complements from innate immunity. Nat Rev Immunol 7:9\u201318","journal-title":"Nat Rev Immunol"},{"key":"648_CR16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","volume":"5","author":"MC Carroll","year":"2004","unstructured":"Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5:981\u2013986","journal-title":"Nat Immunol"},{"key":"648_CR17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2003.11.029","volume":"319","author":"CE Blue","year":"2004","unstructured":"Blue CE, Spiller OB, Blackbourn DJ (2004) The relevance of complement to virus biology. Virology 319:176\u2013184","journal-title":"Virology"},{"key":"648_CR18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.molimm.2004.06.011","volume":"41","author":"P Gasque","year":"2004","unstructured":"Gasque P (2004) Complement: a unique innate immune sensor for danger signals. Mol Immunol 41:1089\u20131098","journal-title":"Mol Immunol"},{"key":"648_CR19","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1128\/JVI.00713-09","volume":"83","author":"JB Johnson","year":"2009","unstructured":"Johnson JB, Grant K, Parks GD (2009) The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 To evade complement-mediated neutralization. J Virol 83:7602\u20137611","journal-title":"J Virol"},{"key":"648_CR20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058\u20131066","journal-title":"N Engl J Med"},{"key":"648_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0952-7915(98)80031-9","volume":"10","author":"PD Stahl","year":"1998","unstructured":"Stahl PD, Ezekowitz RA (1998) The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50\u201355","journal-title":"Curr Opin Immunol"},{"key":"648_CR22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0171-2985(98)80026-0","volume":"199","author":"J Lu","year":"1998","unstructured":"Lu J, Le Y (1998) Ficolins and the fibrinogen like domain. Immunobiology 199:190\u2013199","journal-title":"Immunobiology"},{"key":"648_CR23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.154.3.856","volume":"154","author":"MK Pangburn","year":"1981","unstructured":"Pangburn MK, Schreiber RD, M\u00fcller-Eberhard HJ (1981) Formation of the initial C3 convertase of the alternative pathway: acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med 154:856\u2013867","journal-title":"J Exp Med"},{"key":"648_CR24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","volume":"411","author":"KA Stoermer","year":"2011","unstructured":"Stoermer KA, Morrison TE (2011) Complement and viral pathogenesis. Virology 411:362\u2013373","journal-title":"Virology"},{"key":"648_CR25","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1128\/JVI.00886-12","volume":"86","author":"M Biswas","year":"2012","unstructured":"Biswas M, Johnson JB, Kumar SRP, Parks GD, Subbiaha E (2012) Incorporation of host complement regulatory proteins into newcastle disease virus enhances complement evasion. J Virol 86:12708","journal-title":"J Virol"},{"key":"648_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1743-422X-5-121","volume":"5","author":"A Balakrishnan","year":"2008","unstructured":"Balakrishnan A, Mishra AC (2008) Immune response during acute Chandipura viral infection in experimentally infected susceptible mice. Virol J 5:121","journal-title":"Virol J"},{"key":"648_CR27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1743-422X-8-259","volume":"8","author":"A Balakrishnan","year":"2011","unstructured":"Balakrishnan A, Shahir P (2011) Immune regulation in Chandipura virus infection: characterization of CD4+ T regulatory cells from infected mice. Virol J 8:259","journal-title":"Virol J"},{"key":"648_CR28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2334-12-125","volume":"12","author":"A Balakrishnan","year":"2012","unstructured":"Balakrishnan A, Shahir P (2012) Chandipura Virus infection in mice: the role of toll like receptor 4 in pathogenesis. BMC Infect Dis 12:125","journal-title":"BMC Infect Dis"},{"key":"648_CR29","first-page":"1272","volume":"6","author":"A Balakrishnan","year":"2013","unstructured":"Balakrishnan A, Balasubramaniam GA, Shelke VN, Gunjikar R, Shewale P (2013) Neuro-invasion of Chandipura virus mediates pathogenesis in experimentally infected mice. Int J Clin Exp Pathol 6:1272\u20131281","journal-title":"Int J Clin Exp Pathol"},{"key":"648_CR30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s12879-016-1794-6","volume":"16","author":"S Roy","year":"2016","unstructured":"Roy S, Pavitrakar D, Gunjikar R, Ayachit VM, Bondre VP, Sapkal GN (2016) Monocytes and B cells support active replication of Chandipura virus. BMC Infect Dis 16:487","journal-title":"BMC Infect Dis"},{"key":"648_CR31","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.126.4.1562","volume":"126","author":"DP Beebe","year":"1981","unstructured":"Beebe DP, Cooper NR (1981) Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126:1562\u20131568","journal-title":"J Immunol"},{"key":"648_CR32","first-page":"493","volume":"27","author":"JL Reed","year":"1938","unstructured":"Reed JL, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"648_CR33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2008.03.022","volume":"376","author":"JB Johnson","year":"2008","unstructured":"Johnson JB, Capraro GA, Parks GD (2008) Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses Simian virus 5 and Mumps virus. Virology 376:112\u2013123","journal-title":"Virology"},{"key":"648_CR34","doi-asserted-by":"publisher","first-page":"13.0.1","DOI":"10.1002\/0471142735.im1300s58","volume":"58","author":"EM Shevach","year":"2003","unstructured":"Shevach EM (2003) Chapter 13: Complement. Curr Protoc Immunol 58:13.0.1\u201313.0.4. https:\/\/doi.org\/10.1002\/0471142735.im1300s58","journal-title":"Curr Protoc Immunol"},{"issue":"9","key":"648_CR35","doi-asserted-by":"crossref","first-page":"e2405","DOI":"10.1371\/journal.pntd.0002405","volume":"7","author":"D Parasha","year":"2013","unstructured":"Parasha D, Paingankar Mandar S, Kumar Satyendra, Gokhale Mangesh D, Sudeep AB, Shinde Sapana B, Arankalle VA (2013) Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus. PLoS Negl Trop Dis 7(9):e2405","journal-title":"PLoS Negl Trop Dis"},{"key":"648_CR36","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/iai.11.6.1235-1243.1975","volume":"11","author":"RM Des Prez","year":"1975","unstructured":"Des Prez RM, Bryan CS, Hawiger J, Colley DG (1975) Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-Ethylene glycol tetraacetic acid. Infect Immun 11:1235\u20131243","journal-title":"Infect Immun"},{"key":"648_CR37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2334-8-168","volume":"8","author":"S Kumar","year":"2008","unstructured":"Kumar S, Jadi RS, Anakkathil SB, Tandale BV, Mishra AC, Arankalle VA (2008) Development and evaluation of a real-time one step Reverse-Transcriptase PCR for quantitation of Chandipura Virus. BMC Infect Dis 8:168","journal-title":"BMC Infect Dis"},{"key":"648_CR38","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","volume":"27","author":"M Tiwari","year":"2009","unstructured":"Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PVL (2009) Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Vaccine 27:2513\u20132522","journal-title":"Vaccine"},{"key":"648_CR39","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","volume":"30","author":"M Kumar","year":"2012","unstructured":"Kumar M, Anakkathil SB, Arankalle VA (2012) Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus. Vaccine 30:6142\u20136149","journal-title":"Vaccine"},{"key":"648_CR40","doi-asserted-by":"crossref","first-page":"e41707","DOI":"10.1371\/journal.pone.0041707","volume":"7","author":"E Hammarlund","year":"2012","unstructured":"Hammarlund E, Amanna IJ, Dubois ME, Barron A, Engelmann F (2012) A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus. PLoS One 7:e41707","journal-title":"PLoS One"},{"key":"648_CR41","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1128\/JVI.00193-11","volume":"85","author":"JB Johnson","year":"2011","unstructured":"Johnson JB, Aguilar HC, Lee B, Parks GD (2011) Interactions of human complement with virus particles containing the Nipah virus glycoproteins. J Virol 85:5940\u20135948","journal-title":"J Virol"},{"key":"648_CR42","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.190.8.1165","volume":"190","author":"AF Ochsenbein","year":"1999","unstructured":"Ochsenbein AF, Pinschewer DD, Odermatt B, Carroll MC, Hengartner H, Zinkernagel RM (1999) Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 190:1165\u20131174","journal-title":"J Exp Med"},{"key":"648_CR43","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/JVI.00074-14","volume":"88","author":"MZ Tesfay","year":"2014","unstructured":"Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Stojdl D, Peng KW, Russell SJ (2014) Vesiculovirus neutralization by natural IgM and complement. J Virol 88:6148\u20136157","journal-title":"J Virol"},{"key":"648_CR44","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.124.5.2507","volume":"124","author":"RL Hirsch","year":"1980","unstructured":"Hirsch RL, Winkelstein JA, Griffin DE (1980) The role of complement in viral infections III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol 124:2507\u20132510","journal-title":"J Immunol"},{"key":"648_CR45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.virol.2015.11.012","volume":"488","author":"Hu Shuang","year":"2016","unstructured":"Shuang Hu, Kumar Dipu Mohan, Sax Chelsea, Schuler Clayton, Akkina Ramesh (2016) Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses. Virology 488:162\u2013168","journal-title":"Virology"},{"key":"648_CR46","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.121.4.1549","volume":"121","author":"BJ Mills","year":"1979","unstructured":"Mills BJ, Beebe DP, Cooper NR (1979) Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV lipoprotein complexes in human serum and complement-dependent viral lysis. J Immunol 121:1549\u20131557","journal-title":"J Immunol"},{"key":"648_CR47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj1890173","volume":"189","author":"MA Kerr","year":"1980","unstructured":"Kerr MA (1980) The human complement system: assembly of the classical pathway C3 convertase. Biochem J 189:173\u2013181","journal-title":"Biochem J"},{"key":"648_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-065X.2001.1800103.x","volume":"180","author":"A Sahu","year":"2001","unstructured":"Sahu A, Lambris JD (2001) Structure and biology of complement C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35\u201348","journal-title":"Immunol Rev"},{"key":"648_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00281-017-0661-x","volume":"40","author":"RA Harrison","year":"2018","unstructured":"Harrison RA (2018) The properdin pathway: an \u201calternative activation pathway\u201d or a \u201ccritical amplification loop\u201d for C3 and C5 activation? Semin Immunopathol 40:15\u201335","journal-title":"Semin Immunopathol"},{"key":"648_CR50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/bj2350723","volume":"235","author":"MK Pangburn","year":"1986","unstructured":"Pangburn MK, M\u00fcller-Eberhard HJ (1986) The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem J 235:723\u2013730","journal-title":"Biochem J"},{"key":"648_CR51","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.molimm.2007.11.003","volume":"45","author":"F Bexborn","year":"2008","unstructured":"Bexborn F, Andersson PO, Chen H, Nilsson B, Ekdahl KN (2008) The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol 45:2370\u20132379","journal-title":"Mol Immunol"},{"key":"648_CR52","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.imbio.2012.07.008","volume":"217","author":"B Nilsson","year":"2012","unstructured":"Nilsson B, Nilsson Ekdahl K (2012) The tick-over theory revisited: is C3 a contact-activated protein? Immunobiology 217:1106\u20131110","journal-title":"Immunobiology"},{"key":"648_CR53","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nsmb.3427","volume":"24","author":"X Xue","year":"2017","unstructured":"Xue X, Wu J, Ricklin D, Forneris F, Di Crescenzio P, Schmidt CQ, Granneman J, Sharp TH, Lambris JD (2017) Gros P Regulator dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol 24:643\u2013651","journal-title":"Nat Struct Mol Biol"},{"key":"648_CR54","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","volume":"176","author":"JM Thurman","year":"2006","unstructured":"Thurman JM, Holers VM (2006) The central role of the alternative complement pathway in human disease. J Immunol 176:1305\u20131310","journal-title":"J Immunol"},{"key":"648_CR55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.2004.02627.x","volume":"138","author":"M Harboe","year":"2004","unstructured":"Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004) The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 138:439\u2013446","journal-title":"Clin Exp Immunol"},{"key":"648_CR56","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.179.6.4101","volume":"179","author":"NK Banda","year":"2007","unstructured":"Banda NK, Takahashi K, Wood AK, Holers VM, Arend WP (2007) Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J Immunol 179:4101\u20134109","journal-title":"J Immunol"},{"key":"648_CR57","first-page":"262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I\u2014molecular mechanisms of activation and regulation. Front Immunol 6:262","journal-title":"Front Immunol"},{"key":"648_CR58","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.4049\/jimmunol.165.8.4528","volume":"165","author":"HM Friedman","year":"2000","unstructured":"Friedman HM, Wang L, Pangburn MK, Lambris JD, Lubinski J (2000) Novel mechanism of antibody independent complement neutralization of Herpes Simplex virus type 1. J Immunol 165:4528\u20134536","journal-title":"J Immunol"},{"key":"648_CR59","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1084\/jem.147.3.844","volume":"147","author":"RM Bartholomew","year":"1978","unstructured":"Bartholomew RM, Esser AF, Muller-Eberhard HJ (1978) Lysis of oncornaviruses by human serum Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med 147:844\u2013853","journal-title":"J Exp Med"},{"key":"648_CR60","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1084\/jem.144.4.970","volume":"44","author":"NR Cooper","year":"1976","unstructured":"Cooper NR, Jensen FC, Welsh RM Jr, Oldstone MB (1976) MBA Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 44:970\u2013984","journal-title":"J Exp Med"},{"key":"648_CR61","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.123.6.2518","volume":"123","author":"BJ Mills","year":"1979","unstructured":"Mills BJ, Beebe DP, Cooper NR (1979) Antibody-independent neutralization of vesicular stomatitis virus by human complement II Formation of VSV lipoprotein complexes in human serum and complement-dependent viral lysis. J Immunol 123:2518","journal-title":"J Immunol"},{"issue":"140","key":"648_CR62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.140.2.549","volume":"1974","author":"MBA Oldstone","year":"1974","unstructured":"Oldstone MBA, Cooper NR, Larson DL (1974) Formation and biologic role of polyoma virus-antibody complexes A critical role for complement. J Exp Med 1974(140):549\u2013565","journal-title":"J Exp Med"},{"key":"648_CR63","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.126.4.1562","volume":"126","author":"DP Beebe","year":"1981","unstructured":"Beebe DP, Cooper NR (1981) Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126:1562\u20131568","journal-title":"J Immunol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00648-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-019-00648-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00648-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:37:04Z","timestamp":1744177024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-019-00648-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s00430-019-00648-z","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"19 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Ethical Committee for Research on Humans as per the guidelines of the Indian Council of Medical Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}